Inhibition of lipopolysaccharide-initiated activation of serum complement by polymyxin B.
Treatment of bacterial lipopolysaccharides (endotoxins) isolated from Salmonella minnesota R595 or purified lipid A with the antibiotic polymyxin B has been demonstrated to abrogate the ability of these molecules to activate serum complement. The inhibition is a function of the ratio of polymyxin B...
Kaydedildi:
| Yayımlandı: | Infect Immun |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society for Microbiology (ASM)
1976
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC420610/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/175019/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.13.1.298-301.1976 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|